Medication risk communication with cancer patients in a Middle East cancer care setting.

Purpose: Cancer treatments are frequently associated with adverse effects, but there may be a cultural reluctance by care providers to be forthcoming with patients regarding these risks for fear of promoting nonadherence. Conversely, research in a number of countries indicates high levels of patient desire for this information. We sought to explore cancer patient experiences, satisfaction, and preferences for medication risk communication in a Middle East care setting.

Risk communication with Arab patients with cancer: a qualitative study of nurses and pharmacists.

Objectives: To explore pharmacist and nurse views and experiences in educating patients regarding their treatment safety and tolerability as well as the roles of other professions in this regard.

Design: In this qualitative study, six focus group discussions were conducted.

Setting: The National Center for Cancer Care and Research in Qatar.